Clinical Study on the Efficacy and Safety of Arginine Administered Orally in Association with Other Active Ingredients for the Prevention and Treatment of Sarcopenia in Patients with COVID-19-Related Pneumonia, Hospitalized in a Sub-Intensive Care Unit

In order to evaluate the efficacy of oral supplementation with 3 g of arginine per day associated with creatine, L-carnitine, aspartic acid, magnesium, selenium and vitamins C and E (Argivit© Aesculapius Farmaceutici) in the prevention and treatment of sarcopenia in patients with COVID-19-related pn...

Descripción completa

Detalles Bibliográficos
Autores principales: Bologna, Carolina, Pone, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776134/
https://www.ncbi.nlm.nih.gov/pubmed/35052325
http://dx.doi.org/10.3390/healthcare10010162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776134/
https://www.ncbi.nlm.nih.gov/pubmed/35052325
http://dx.doi.org/10.3390/healthcare10010162

Ejemplares similares